All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @tiktoknutritionist on TikTok · 67s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @tiktoknutritionist's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Are you taking a GLP1 medication?
  2. 0:02Well, these five foods can make or break your results, especially number five.
  3. 0:06Number one, avocado.
  4. 0:08The good fat and fiber found in avocado naturally supports GLP1 for appetite regulation and
  5. 0:13steady energy.
  6. 0:15Number two, eggs.
  7. 0:17This versatile high-quality protein helps to prevent muscle loss, helping to prevent
  8. 0:21against the slowing metabolism.
  9. 0:23Number three, chia seeds.
  10. 0:25These tiny seeds pack in the fiber to support digestive health and fight against constipation.
  11. 0:30Just one tablespoon can go a long way in helping you to reach your daily fiber goals.
  12. 0:34Number four, cucumber.
  13. 0:35This water-rich food can help to fight dehydration, a common side effect of GLP1 medications, while
  14. 0:41providing a boost of fiber and antioxidants.
  15. 0:44Number five, replenza.
  16. 0:46Even with a balanced diet, GLP1 medications can leave nutritional gaps, and that's where
  17. 0:50replenza comes in.
  18. 0:52This physician-formulated supplement is designed specifically for GLP1 users to support energy,
  19. 0:57digestion, and overall wellness while on your weight loss journey.
  20. 1:01Want to feel your best on a GLP1?
  21. 1:03Then make sure to save this list and tag a friend who needs to see it too.

GLP-1 diet tips on TikTok: helpful hacks or sponsored noise?

Erin Palinski-Wade, RD, CDCES

TikTok creator

12.8K viewsWatch on TikTok

Quick answer

GLP-1 receptor agonists like semaglutide and tirzepatide suppress appetite significantly, which reduces total caloric intake and can create protein and micronutrient shortfalls if diet quality is poor. Gastrointestinal side effects including nausea, constipation, and vomiting are well-documented in phase 3 trial data and can compound nutritional challenges. Dietary support strategies, particularly adequate protein and fiber intake, are recommended by obesity medicine guidelines, but no supplement has been clinically validated specifically for GLP-1 users.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 diet tips on TikTok: helpful hacks or sponsored noise?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GLP-1 diet tips on TikTok: helpful hacks or sponsored noise? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 diet tips on TikTok: helpful hacks or sponsored noise?" from Erin Palinski-Wade, RD, CDCES. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists like semaglutide and tirzepatide suppress appetite significantly, which reduces total caloric intake and can create protein and micronutrient shortfalls if diet quality is poor.

The reason this review is not generic is the source wording and the canonical claim label "glp1 ad taking a glp 1 for weight loss these 5 foods can make or." In this clip, the useful excerpt is: "Are you taking a GLP1 medication?" That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Constipation affects roughly 5-30% of GLP-1 users depending on medication and dose, per the STEP trial adverse event data, so fiber recommendations have real clinical backing.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GLP-1 receptor agonists like semaglutide and tirzepatide suppress appetite significantly, which reduces total caloric intake and can create protein and micronutrient shortfalls if diet quality is poor.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists like semaglutide and tirzepatide suppress appetite significantly, which reduces total caloric intake and can create protein and micronutrient shortfalls if diet quality is poor. Gastrointestinal side effects including nausea, constipation, and vomiting are well-documented in phase 3 trial data and can compound nutritional challenges. Dietary support strategies, particularly adequate protein and fiber intake, are recommended by obesity medicine guidelines, but no supplement has been clinically validated specifically for GLP-1 users.
  • Protein intake matters on GLP-1 therapy: the STEP 1 trial data (Wilding et al., 2021, NEJM) showed lean mass loss alongside fat loss on semaglutide, making adequate protein intake a legitimate priority.
  • Constipation affects roughly 5-30% of GLP-1 users depending on medication and dose, per the STEP trial adverse event data, so fiber recommendations have real clinical backing.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Protein intake matters on GLP-1 therapy: the STEP 1 trial data (Wilding et al., 2021, NEJM) showed lean mass loss alongside fat loss on semaglutide, making adequate protein intake a legitimate priority.
  • Constipation affects roughly 5-30% of GLP-1 users depending on medication and dose, per the STEP trial adverse event data, so fiber recommendations have real clinical backing.
  • The avocado-GLP-1 synergy claim is plausible in theory but overstated in practice. Dietary fat stimulates endogenous GLP-1 release, but the effect is not specific to avocado and is not pharmacologically significant.
  • No supplement, including Replenza, has been evaluated in a peer-reviewed clinical trial for nutritional gap management in GLP-1 medication users. 'Physician-formulated' is marketing language, not a clinical standard.
  • If GLP-1 side effects are severe enough to impair eating or cause dehydration, the appropriate response is contact with a prescriber, not dietary adjustments found on TikTok.
  • A registered dietitian with bariatric or metabolic specialization can provide individualized guidance on eating patterns during GLP-1 therapy that a short-form social video cannot replicate.
  • The #AD disclosure is present in this video, but the editorial-style format blurs the line between dietary advice and product promotion, which warrants viewer skepticism on any supplement recommendation made in this context.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @tiktoknutritionist actually say?

In a sponsored TikTok, the creator listed five things they claim can "make or break" results for people on GLP-1 medications. Four of them are real foods: avocado, eggs, chia seeds, and cucumber. The fifth is a paid promotion for Replenza, a supplement brand. The creator said avocado "naturally supports GLP-1 for appetite regulation," that eggs "prevent against the slowing metabolism," that chia seeds fight constipation, that cucumber fights dehydration "a common side effect of GLP-1 medications," and that Replenza fills "nutritional gaps" left by GLP-1 drugs. The #AD and #replenzapartner hashtags confirm this is a commercial arrangement, though the transition from food tips to product pitch is seamless enough that casual viewers could easily miss it.

Does the science back this up?

Some of it, yes. But the framing is doing a lot of heavy lifting. The food recommendations are broadly reasonable, but the specific mechanistic claims range from oversimplified to unsupported.

On avocado: monounsaturated fats and fiber do slow gastric emptying and can reduce postprandial hunger, but saying avocado "naturally supports GLP-1" implies it boosts endogenous GLP-1 secretion. There is some evidence for this. Rebello et al. (2013, Nutrition Journal) found that avocado consumption increased satiety, and animal studies suggest dietary fats stimulate L-cell GLP-1 release. However, this effect is modest and not specific to avocado. Many foods trigger GLP-1 release. Calling it out as uniquely supportive overstates the case.

On eggs: high-quality protein does help preserve lean mass during caloric restriction. Paddon-Jones et al. (2008, American Journal of Clinical Nutrition) confirmed that adequate protein intake is protective against muscle loss. This claim is the most defensible of the four.

On chia seeds: fiber does support gut motility and constipation is a documented side effect of GLP-1 receptor agonists, reported in roughly 5-30% of users depending on the drug and dose (Davies et al., 2021, New England Journal of Medicine, semaglutide STEP trials). One tablespoon of chia seeds provides about 5g of fiber, which is useful but not transformative on its own.

On cucumber: cucumber is about 96% water, so yes, it contributes to hydration. But framing it as a weapon against GLP-1-induced dehydration is a stretch. GLP-1 medications cause nausea and vomiting that can lead to fluid loss, and the solution there is medical management, not cucumber slices.

What did they get wrong (or right)?

The food recommendations are not bad dietary advice for anyone eating a reduced-calorie diet, GLP-1 user or not. That is genuinely worth acknowledging. Protein, fiber, and hydration all matter more when you are eating significantly less food.

What they got wrong: the mechanistic framing. Saying avocado "naturally supports GLP-1" implies a pharmacological-level interaction that the evidence does not support at normal serving sizes. Similarly, saying eggs prevent "the slowing metabolism" suggests a protective effect on metabolic rate that has not been demonstrated in GLP-1 users specifically. Muscle preservation and resting metabolic rate are related but not the same thing.

The bigger problem is item five. Describing Replenza as filling "nutritional gaps" that GLP-1 medications specifically create is an unverified claim. There is no published clinical evidence that Replenza addresses deficiencies caused by semaglutide or tirzepatide. The phrase "physician-formulated" is marketing language, not a regulatory designation. Supplements are not FDA-approved to treat or prevent nutritional deficiencies in this context. The ad disclosure is present but easy to miss given the seamless editorial framing.

What should you actually know?

If you are on a GLP-1 medication, your appetite suppression is real and significant. Eating less means you have less room for micronutrients, and protein and fiber become proportionally more important. The dietary advice here is directionally correct, even if the specific mechanistic claims are fuzzy.

What this video does not tell you: GLP-1 medications can cause nausea, vomiting, and reduced appetite severe enough that some users struggle to eat adequately at all. If you are experiencing significant side effects, talking to your prescriber matters more than any food list. Muscle loss during rapid weight loss is a real concern. The STEP 1 extension data (Wilding et al., 2021, New England Journal of Medicine) showed that lean mass loss accompanies fat loss on semaglutide, which is why protein intake is worth prioritizing.

On supplements: there is no clinical evidence base supporting the use of any GLP-1-specific supplement for nutritional gap filling. If you are concerned about micronutrient status while on a GLP-1 medication, a blood panel ordered by your doctor is more useful than a subscription box. Registered dietitians who work with bariatric or metabolic patients can provide individualized guidance that a 60-second TikTok cannot.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Erin Palinski-Wade, RD, CDCES · TikTok creator

12.8K views on this video

#AD Taking a GLP-1 for weight loss? 🩺✨These 5 foods can make or break your progress—especially #5 👀⁠ ⁠ 🥑 Avocado for appetite regulation⁠ ⁠ 🍳 Eggs to protect your metabolism⁠ ⁠ 🌱 Chia seeds to fight constipation⁠ ⁠ 🥒 Cucumber to prevent dehydration⁠ ⁠ 💊 @ReplenzaLabs to fill in nutritional gaps (game-changer!) This physician formulated supplement is designed specifically for GLP-1 users & contains the essential vitamins, minerals, and electrolytes you need for optimal hydration & nut

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about protein intake matters on glp-1 therapy: the step 1 trial?

Protein intake matters on GLP-1 therapy: the STEP 1 trial data (Wilding et al., 2021, NEJM) showed lean mass loss alongside fat loss on semaglutide, making adequate protein intake a legitimate priority.

What does the video say about constipation affects roughly 5-30% of glp-1 users depending on medication?

Constipation affects roughly 5-30% of GLP-1 users depending on medication and dose, per the STEP trial adverse event data, so fiber recommendations have real clinical backing.

What does the video say about the avocado-glp-1 synergy claim?

The avocado-GLP-1 synergy claim is plausible in theory but overstated in practice. Dietary fat stimulates endogenous GLP-1 release, but the effect is not specific to avocado and is not pharmacologically significant.

What does the video say about no supplement, including replenza, has been evaluated in a peer-reviewed?

No supplement, including Replenza, has been evaluated in a peer-reviewed clinical trial for nutritional gap management in GLP-1 medication users. 'Physician-formulated' is marketing language, not a clinical standard.

What does the video say about if glp-1 side effects?

If GLP-1 side effects are severe enough to impair eating or cause dehydration, the appropriate response is contact with a prescriber, not dietary adjustments found on TikTok.

What does the video say about a registered dietitian with bariatric?

A registered dietitian with bariatric or metabolic specialization can provide individualized guidance on eating patterns during GLP-1 therapy that a short-form social video cannot replicate.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Erin Palinski-Wade, RD, CDCES, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.